Characteristics, treatment patterns, and glycemic control of older type 2 diabetes mellitus patients in China.
10.1097/CM9.0000000000001674
- Author:
Xiao-Ling CAI
1
;
Jie SHEN
2
;
Bin-Qi YE
3
;
Qiang LI
4
;
Douglas A S CLARK
5
;
Li-Nong JI
1
Author Information
1. Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing 100044, China.
2. Department of Medical Affairs, Boehringer Ingelheim (China) Investment Co., Ltd., Shanghai 200040, China.
3. Department of Biostatistics & Data Sciences Asia, Boehringer Ingelheim (China) Investment Co., Ltd., Shanghai 200040, China.
4. Department of Global Epidemiology, Boehringer Ingelheim (China) Investment Co., Ltd., Beijing 100027, China.
5. Boehringer Ingelheim International GmbH, Binger Strasse 173, 55216 Ingelheim am Rhein, Germany.
- Publication Type:Letter
- MeSH:
Blood Glucose;
China;
Diabetes Mellitus, Type 2/drug therapy*;
Glycated Hemoglobin A/analysis*;
Glycemic Control;
Humans;
Hypoglycemic Agents/therapeutic use*
- From:
Chinese Medical Journal
2021;134(23):2893-2895
- CountryChina
- Language:English
